2014
Low-to-moderate prenatal alcohol consumption and the risk of selected birth outcomes: a prospective cohort study
Lundsberg LS, Illuzzi JL, Belanger K, Triche EW, Bracken MB. Low-to-moderate prenatal alcohol consumption and the risk of selected birth outcomes: a prospective cohort study. Annals Of Epidemiology 2014, 25: 46-54.e3. PMID: 25453352, PMCID: PMC4255148, DOI: 10.1016/j.annepidem.2014.10.011.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol DrinkingConfidence IntervalsConfounding Factors, EpidemiologicConnecticutFemaleFetal Growth RetardationGestational AgeHumansInfant, Low Birth WeightInfant, NewbornLogistic ModelsMassachusettsMaternal-Fetal ExchangeOdds RatioPregnancyPregnancy ComplicationsPregnancy OutcomePremature BirthProspective StudiesRisk FactorsConceptsIntrauterine growth restrictionLow birthweightPreterm deliveryBirth lengthBirth outcomesGrowth restrictionAlcohol exposureOdds ratioLower oddsModerate prenatal alcohol exposureModerate alcohol exposureThird-trimester drinkingProspective cohort studyMultivariable logistic regressionConfidence intervalsPrenatal alcohol consumptionPrenatal alcohol exposurePregnancy drinkingNeonatal outcomesPerinatal outcomesSingleton infantsCohort studyAlcohol drinkingReduced oddsHead circumference
2007
Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy.
Urban G, Vergani P, Tironi R, Ceruti P, Vertemati E, Sala F, Pogliani E, Triche EW, Lockwood CJ, Paidas MJ. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. International Journal Of Fertility And Women's Medicine 2007, 52: 59-67. PMID: 18320863.Peer-Reviewed Original ResearchMeSH KeywordsAdultAspirinCohort StudiesConfidence IntervalsDrug Therapy, CombinationFemaleFetal Growth RetardationFibrinolytic AgentsHeparin, Low-Molecular-WeightHumansInfant, NewbornLogistic ModelsOdds RatioParityPre-EclampsiaPregnancyRetrospective StudiesRisk FactorsSecondary PreventionWomen's HealthConceptsLow-dose aspirinAdverse pregnancy outcomesIntrauterine growth restrictionSevere preeclampsiaIndex pregnancyProphylactic low-dose aspirinRetrospective cohort studyIntrauterine growth retardationCohort of womenLogistic regression modelsAntithrombotic prophylaxisAntecedent pregnancyDose aspirinMultiparous patientsCohort studyMultiparous womenPregnancy outcomesWeight heparinGrowth restrictionOdds ratioPrevious historyGrowth retardationCombined treatmentLMWHPregnancy
2006
Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction
Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR, Bracken MB. Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction. American Journal Of Epidemiology 2006, 163: 1035-1041. PMID: 16641310, DOI: 10.1093/aje/kwj125.Peer-Reviewed Original ResearchConceptsIntrauterine growth restrictionRisk of IUGRUmbilical cord bloodGrowth restrictionCord bloodCaffeine consumptionRatio of paraxanthineCytochrome PSelf-reported caffeine consumptionPreterm deliveryFetal exposureHighest quartileAdjusted analysisPregnant womenFetal growthObstetric practiceCYP1A2 activityParaxanthine levelsReproductive outcomesAdjusted modelAssociation of caffeineCaffeine metabolitesStandard deviation changeConflicting resultsQuartile
2005
Immunogenetic Determinants of Preeclampsia and Related Pregnancy Disorders
Saftlas A, Beydoun H, Triche E. Immunogenetic Determinants of Preeclampsia and Related Pregnancy Disorders. Obstetrics And Gynecology 2005, 106: 162-172. PMID: 15994633, DOI: 10.1097/01.aog.0000167389.97019.37.Peer-Reviewed Original ResearchConceptsIntrauterine growth restrictionRisk of preeclampsiaGrowth restrictionHuman leukocyte antigen (HLA) allele frequenciesMaternal homozygosityPossible etiologic factorsHLA-DR locusSpecific HLA allelesAdditional pertinent studiesBasic science research studiesHLA allele frequenciesImmunogenetic factorsOriginal research studiesExposure definitionPregnancy disordersEtiologic factorsHLA genotypeSTUDY SELECTIONHLA sharingImmunogenetic determinantsPreeclampsiaHLA allelesPubMed databaseYielded inconsistent resultsComputerized search
2003
Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies.
Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstetrics And Gynecology 2003, 102: 739-52. PMID: 14551004, DOI: 10.1016/s0029-7844(03)00621-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Asthmatic AgentsAnti-Inflammatory AgentsAsthmaBirth WeightCase-Control StudiesConnecticutFemaleFetal Growth RetardationFetal Membranes, Premature RuptureHumansInfant, Low Birth WeightInfant, NewbornMassachusettsPregnancyPregnancy ComplicationsPregnancy OutcomeProspective StudiesRisk FactorsSeverity of Illness IndexSteroidsTheophyllineConceptsAsthma symptomsOral steroidsAsthma diagnosisPreterm deliveryPregnant womenHistory of asthmaIntrauterine growth restrictionIUGR infantsAsthma guidelinesAsthma historyController medicationsModerate asthmaAsthma therapyPregnant patientsSymptomatic patientsAsthma severityFetal effectsSymptomatic womenProspective studyDrug therapyGrowth restrictionAsthmaSymptomsMedicationsDiagnosisAssociation of Maternal Caffeine Consumption with Decrements in Fetal Growth
Bracken MB, Triche EW, Belanger K, Hellenbrand K, Leaderer BP. Association of Maternal Caffeine Consumption with Decrements in Fetal Growth. American Journal Of Epidemiology 2003, 157: 456-466. PMID: 12615610, DOI: 10.1093/aje/kwf220.Peer-Reviewed Original ResearchConceptsMaternal caffeine consumptionIntrauterine growth retardationCaffeine consumptionBirth weightCreatinine increaseUrinary caffeineGrowth retardationFirst prenatal visitLarge prospective studiesLow birth weightMean birth weightImportant confounding factorsFetal hazardsPerinatal outcomesPreterm deliveryCreatinine levelsPregnancy outcomesPrenatal visitUrinary cotinineGestational ageSingleton livebirthsThird trimesterProspective studyFetal growthMedical records